ACE2 and COVID-19: In SARS-CoV-2 infection, butyrate has been shown to be effective in regulating the expression of ACE2, proinflammatory cytokines and other genes linked to the progression and disease outcomes of COVID-19 [75] and are predicted to be low in severe COVID-19 [76].